Related Experiment Videos
Allergic conjunctivitis as a risk factor for laser in situ keratomileusis
N Asano-Kato1, I Toda, Y Hori-Komai
1Minamiaoyama Eye Clinic, Tokyo, Japan. naokato@bc.iij4u.or.jp
Journal of Cataract and Refractive Surgery
|September 22, 2001
Summary
Allergic conjunctivitis (AC) does not negatively impact laser in situ keratomileusis (LASIK) outcomes. This study found no significant differences in visual acuity or refraction in patients with AC undergoing LASIK.
Area of Science:
- Ophthalmology
- Refractive Surgery
- Corneal Surgery
Background:
- Allergic conjunctivitis (AC) is a common condition affecting the eyes.
- The impact of AC on the outcomes of refractive surgery, specifically LASIK, requires thorough investigation.
Purpose of the Study:
- To investigate the effect of pre-existing allergic conjunctivitis (AC) on the outcomes of laser in situ keratomileusis (LASIK).
- To determine if AC is a risk factor for complications or reduced visual outcomes after LASIK surgery.
Main Methods:
- A comparative study was conducted at Minamiaoyama Eye Clinic, Tokyo.
- Patients undergoing LASIK were divided into two groups: those with AC (allergic group, 84 eyes) and those without AC (nonallergic group, 140 eyes).
- Preoperative and postoperative uncorrected visual acuity (UCVA), refraction, and intraoperative/postoperative complications were compared between the groups.
Main Results:
- No significant differences in UCVA or refraction were observed between the allergic and nonallergic groups.
- The allergic group experienced no complications during or after LASIK surgery.
- The nonallergic group had instances of intraoperative conjunctival chemosis and a postoperative epithelial defect leading to epithelial ingrowth.
Conclusions:
- Allergic conjunctivitis (AC) does not appear to be a risk factor for LASIK outcomes.
- LASIK surgery can be safely performed in myopic patients with allergic conjunctivitis.
- The study suggests that careful preoperative assessment can mitigate potential risks in patients with AC.